Guenther Witzany | Biochemistry, Genetics and Molecular Biology | Excellence in Research Award

Published on by Best Paper Awards

Excellence in Research Award

Guenther Witzany
Telos – Philosophische Praxis

Guenther Witzany
Researcher Guenther Witzany
Affiliation Telos – Philosophische Praxis
Country Austria
Scopus ID 14629725000
Documents 29
Citations 288
h-index 11
Subject Area Biochemistry, Genetics and Molecular Biology
Event International Research Excellence and Best Paper Awards

Guenther Witzany, affiliated with Telos – Philosophische Praxis, Austria, is recognized through the Excellence in Research Award for his scholarly contributions to biocommunication theory, evolutionary biology, genetics, and molecular biology. His interdisciplinary work explores communication processes within living systems and advances understanding of biological information exchange. The recognition reflects a sustained publication record, measurable citation impact, and contributions to contemporary scientific discourse within the broader field of molecular and evolutionary sciences.[1]

Abstract

The Excellence in Research Award acknowledges the academic contributions of Guenther Witzany in advancing interdisciplinary understanding of communication processes in living systems. His work integrates concepts from molecular biology, genetics, evolution, and philosophy of science to examine how biological entities generate, exchange, and interpret information. Through publications, theoretical frameworks, and scholarly engagement, Witzany has contributed to discussions concerning biological signaling, genetic regulation, and evolutionary adaptation. His research profile demonstrates sustained productivity, international visibility, and measurable scientific influence, supporting recognition within the International Research Excellence and Best Paper Awards program.[2]

Keywords

Biocommunication, Molecular Biology, Evolutionary Theory, Genetics, Biological Signaling, Scientific Communication, Systems Biology, Research Excellence.

Introduction

Modern biological research increasingly recognizes communication and information exchange as fundamental components of living systems. Guenther Witzany has contributed to this perspective by examining the role of signaling processes across organisms and biological structures. His work bridges scientific and philosophical approaches, offering frameworks that help explain regulatory interactions within genetics, cellular systems, and evolutionary processes. Such interdisciplinary scholarship contributes to broader understanding of biological complexity and adaptive behavior.[3]

Research Profile

Guenther Witzany’s research profile reflects expertise in molecular biology, genetics, evolutionary studies, and theoretical biology. His scholarly activities emphasize communication-based interpretations of biological processes and the significance of information exchange in living organisms. With a documented publication record and international citations, his work contributes to academic discussions regarding the mechanisms through which biological systems coordinate, regulate, and evolve.[1]

Research Contributions

A significant aspect of Witzany’s scholarship involves the development of biocommunication theory, which investigates how organisms employ signs, signals, and contextual interactions. His research highlights the communicative dimensions of cellular activity, genetic regulation, and evolutionary adaptation. These contributions have provided conceptual models used to interpret biological organization beyond purely mechanistic explanations, encouraging interdisciplinary dialogue among researchers from multiple scientific domains.[4]

Publications

  • Biocommunication and Natural Genome Editing.
  • Introduction to Biosemiotics: The New Biological Synthesis.
  • Biocommunication of Fungi.
  • Biocommunication of Plants.
  • Communication and Information Exchange in Evolutionary Systems.

Research Impact

The research impact of Guenther Witzany is reflected through citation performance, continued scholarly engagement, and the adoption of communication-centered perspectives within biological sciences. His publications have contributed to discussions regarding genome regulation, evolutionary innovation, and biological information processing. By encouraging integration between empirical research and conceptual analysis, his work has influenced interdisciplinary investigations across molecular biology and related scientific fields.[2]

Award Suitability

The Excellence in Research Award recognizes sustained scholarly achievement, publication quality, citation influence, and contributions to advancing scientific understanding. Guenther Witzany’s interdisciplinary research portfolio aligns with these criteria through his established record of publications, measurable research impact, and continued engagement with emerging questions in genetics, molecular biology, and evolutionary theory. His work demonstrates both academic rigor and relevance to contemporary scientific inquiry.[5]

Conclusion

Guenther Witzany’s research contributions illustrate the value of interdisciplinary approaches in understanding biological systems. Through investigations of communication, information exchange, and evolutionary processes, he has contributed to scientific discussions that extend across multiple domains of biology. His publication record, citation performance, and conceptual innovations support recognition through the Excellence in Research Award and highlight the continuing relevance of his scholarly work within contemporary life sciences.

References

  1. Elsevier. (n.d.). Scopus author details: Guenther Witzany, Author ID 14629725000. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=14629725000
  2. Witzany, G. (2016). The biocommunication method: On the road to an integrative biology. Taylor & Francis.
    https://doi.org/10.1080/19420889.2016.1164374
  3. Witzany, G. (2025). Plant Growth and Development from Biocommunication Perspective. MDPI.
    https://doi.org/10.3390/ijpb16020063
  4. Witzany, G. (2012). Introduction: Keylevels of Biocommunication of Ciliates. Springer.
    https://doi.org/10.1007/978-3-319-32211-7_1
  5. International Research Excellence and Best Paper Awards. (n.d.). Award Evaluation and Recognition Framework.
    https://bestpaperawards.com/

Frederic Harb | Biochemistry | Research Excellence Award

Published on by Best Paper Awards

Research Excellence Award

Frederic Harb
University of Balamand, Lebanon

Frederic Harb
Affiliation University of Balamand
Country Lebanon
Scopus ID 55509977300
Documents 56
Citations 462
h-index 14
Subject Area Biochemistry
Event Best Paper Awards
ORCID 0000-0001-5882-1619

This academic article summarizes the scholarly profile, research activity, and scientific contributions of Frederic Harb of the University of Balamand. The article presents a concise overview of publication performance, citation indicators, research impact, and suitability for recognition through the Research Excellence Award program.[1]

Abstract

Frederic Harb is a researcher affiliated with the University of Balamand whose academic work is primarily associated with biochemistry and related biomedical investigations. Based on available bibliometric indicators, the researcher has produced 56 indexed documents, accumulated 462 citations, and achieved an h-index of 14. These metrics indicate sustained scholarly activity and measurable influence within the scientific literature. The profile demonstrates engagement in peer-reviewed research, interdisciplinary collaboration, and knowledge dissemination. This article provides a concise assessment of research achievements, publication performance, scientific impact, and relevance to the objectives of the Research Excellence Award.[1]

Keywords

Biochemistry, Research Excellence Award, Scientific Publications, Citation Impact, Academic Recognition, Scholarly Contributions, University of Balamand, Research Assessment.

Introduction

Research evaluation commonly considers publication productivity, citation influence, and scholarly engagement. Frederic Harb has developed a documented academic profile within biochemistry, contributing to scientific literature through peer-reviewed publications and collaborative investigations. Such indicators provide a foundation for assessing research quality and academic standing.[1]

Research Profile

The researcher is affiliated with the University of Balamand in Lebanon. Bibliometric records indicate 56 indexed publications, 462 citations, and an h-index of 14. These metrics reflect continuing participation in scholarly communication and demonstrate an established presence within the academic research community.[1]

Research Contributions

Research contributions have focused on biochemistry and related scientific disciplines. Published studies contribute to understanding biological mechanisms and biomedical applications. Through collaborative investigations and peer-reviewed dissemination, the researcher has supported the advancement of scientific knowledge and promoted evidence-based research practices.[2]

Publications

The publication record includes 56 indexed documents covering diverse aspects of biochemistry. These outputs have appeared in peer-reviewed scholarly venues and contribute to scientific discourse. Publication activity demonstrates consistency in research engagement and participation in internationally recognized academic communication channels.[1]

Research Impact

Citation indicators provide evidence of research visibility and scholarly influence. With 462 citations and an h-index of 14, the researcher’s work has been referenced by other academics, demonstrating relevance within the scientific community. These metrics indicate measurable impact and ongoing recognition of published findings.[1]

Award Suitability

The available academic indicators suggest suitability for consideration within research recognition programs. Publication productivity, citation performance, and demonstrated scholarly engagement align with common evaluation criteria used by academic award committees when assessing scientific achievement and contribution to disciplinary advancement.[3]

Conclusion

Frederic Harb has established a documented research profile characterized by peer-reviewed publications, citation impact, and scientific engagement. The available evidence supports recognition of sustained academic contributions and highlights the researcher’s role in advancing biochemistry-related scholarship through scholarly communication and collaborative research activities.

References

  1. Elsevier. (n.d.). Scopus author details: Frederic Harb, Author ID 55509977300. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=55509977300
  2. ORCID. (n.d.). Research activities and scholarly profile of Frederic Harb.
    https://orcid.org/0000-0001-5882-1619

  3. Assessing Drug Administration Techniques in Zebrafish Models of Neurological Disease.
    https://www.mdpi.com/1422-0067/24/19/14898

  4. Mechanisms, Biomarkers, and Treatment Approaches for Diabetic Kidney Disease: Current Insights and Future Perspectives.
    https://www.mdpi.com/2077-0383/14/3/727

P. V. G. K Sarma | Biochemistry | Editorial Board Member

Published on by Best Paper Awards

Assoc. Prof. Dr. P. V. G. K Sarma | Biochemistry | Editorial Board Member 

Associate Professor | Sri Venkateswara Institute of Medical Sciences | India

P. V. G. K. Sarma is a senior Indian biotechnologist and academic leader currently serving as the Head of the Department of Biotechnology at the Sri Venkateswara Institute of Medical Sciences, Tirupati, a position he has held since 2004, with his academic training from JNTU Hyderabad and a broad research portfolio reflected in over a hundred scholarly publications indexed across major journals. P. V. G. K. Sarma His core research spans genetic engineering, microbial biotechnology, functional genomics, structural bioinformatics, and stem cell differentiation with a strong translational focus on regenerative medicine and human disease. A major strength of his work lies in the in vitro differentiation of human CD34+ hematopoietic stem cells into diverse lineages including pancreatic β-cells, erythrocytes, podocytes, type-II pneumocytes, keratinocytes, chondrocytes, and megakaryocytes, contributing to the understanding of cellular plasticity and therapeutic cell generation. Parallel to this, he has made significant contributions to microbial pathogenesis, particularly on Staphylococcus aureus, elucidating molecular mechanisms of biofilm formation, metabolic regulation, and antimicrobial resistance, including MRSA, through gene expression, enzyme activity, and structure-based drug design approaches. His interdisciplinary research also addresses clinical and molecular genetics, with notable studies on mutations linked to congenital erythrocytosis, breast cancer, leukemia drug resistance, rheumatoid arthritis, tuberculosis susceptibility, cardiovascular disease, and pain genetics. During the COVID-19 period, his in silico investigations on antiviral compounds targeting SARS-CoV-2 proteins further demonstrated his adaptability across emerging biomedical challenges. He has consistently integrated wet-lab experimentation with computational biology, signaling pathways, and nanobiotechnology, including cytotoxicity studies of silver nanoparticles on human stem cells. Beyond research, he is actively involved in peer review for reputed international journals and contributes to clinical translational science through collaborations across medicine, genetics, and biotechnology. Collectively, his career reflects sustained leadership in Indian biomedical research, with impactful contributions to stem cell biology, microbial biotechnology, and molecular genetics aimed at advancing diagnostics, therapeutics, and regenerative strategies.

Profile: ORCID

Featured Publications

  1. Chandrasekhar, C., Kumar, P. S., & Sarma, P. V. G. K. (2019). Novel mutations in the kinase domain of BCR-ABL gene causing imatinib resistance in chronic myeloid leukemia patients. Scientific Reports, 9, 38672.

  2. Loganathan, S. E., Kattaru, S., Kodavala, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). Prominent expression of COL2A1, ACAN and IHH genes observed in the differentiation of human hematopoietic stem cells into articular type of chondrocytes. Stem Cell Reviews and Reports, 20.

  3. Kodavala, S., Loganathan, S. E., Kattaru, S., Chandrasekhar, C., & Sarma, P. V. G. K. (2024). In vitro generation of epidermal keratinocytes from human CD34-positive hematopoietic stem cells. In Vitro Cellular & Developmental Biology – Animal, 60.

  4. Suthi, S., Mounika, A., & Sarma, P. V. G. K. (2023). Elevated acetate kinase (ackA) gene expression, activity, and biofilm formation observed in methicillin-resistant strains of Staphylococcus aureus. Journal of Genetic Engineering and Biotechnology, 21.

  5. Kattaru, S., Manne Mudhu, S., Loganathan, S. E., Kodavala, S., & Sarma, P. V. G. K. (2021). Increased insulin and GLUT2 gene expression and elevated glucokinase activity in β-like cells of islets of Langerhans differentiated from human haematopoietic stem cells on treatment with Costus igneus leaf extract. Molecular Biology Reports, 48.

P. V. G. K. Sarma has advanced translational biotechnology through pioneering stem cell differentiation, molecular genetics, and microbial pathogenesis research that directly supports regenerative medicine and precision diagnostics. His work bridges laboratory science with clinical and industrial applications, contributing to improved disease understanding, therapeutic development, and global biomedical innovation.

Dr. Mostafa Saberian | Biochemistry | Best Researcher Award

Published on by Best Paper Awards

Dr. Mostafa Saberian | Biochemistry | Best Researcher Award

Lecturer | Tehran University of Medical Sciences | Iran

Prof. Mostafa Saberian is highly suitable for the Best Researcher Award, reflecting a distinguished career in medical laboratory sciences at Tehran University of Medical Sciences since 2009, with prior professional activity dating back to 2008. His research contributions encompass a diverse range of impactful studies, including molecular and clinical investigations on calcium channels in anesthesia, innovative hydrogel-based approaches for tissue engineering and wound healing, and regenerative medicine applications using mesenchymal stem cells. Notably, his work has been published in high-quality journals such as Molecular Pain, Tissue Engineering Part B: Reviews, Heliyon, and the Journal of Professional Nursing, demonstrating both breadth and depth in biomedical research. He has also made significant contributions to clinical studies, including investigations on fluid balance in post-operative acute kidney injury and the impact of probiotics and natural compounds on cellular proliferation, highlighting a translational focus bridging laboratory research and clinical applications. Beyond his publications, Prof. Saberian has actively engaged in peer review, contributing 33 reviews across seven prestigious journals, which underscores his commitment to advancing scientific rigor and supporting the broader research community. His interdisciplinary approach, combining molecular biology, tissue engineering, regenerative medicine, and clinical insights, reflects innovative thinking and a capacity to address complex biomedical challenges. Additionally, his collaboration with both national and international researchers emphasizes his ability to foster partnerships and contribute to global scientific discourse. Overall, Prof. Saberian’s sustained scholarly productivity, impactful research outputs, and dedication to mentoring and peer review make him a highly deserving candidate for the Best Researcher Award, recognizing not only his academic excellence but also his leadership and influential presence in advancing medical and biomedical sciences at both national and international levels.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Saberian, M., Shamsi, A., Mohseni, M. M., Taghizadehimani, A., & Shahidi Delshad, E. (2025). Calcium channels in anesthesia management: A molecular and clinical review. Molecular Pain.

  2. Molaei, R., Hosseinkhani, A., & Saberian, M. (2025). Molecular regulation of tissue remodeling through chitosan-based hydrogels in wound healing dynamics. Tissue Engineering Part B: Reviews.

  3. Saberian, M., Safari Roudsari, R., Haghshenas, N., Rousta, A., & Alizadeh, S. (2024). How the combination of alginate and chitosan can fabricate a hydrogel with favorable properties for wound healing. Heliyon.

  4. Saberian, M., Abak, N. (2024). Hydrogel-mediated delivery of platelet-derived exosomes: Innovations in tissue engineering. Heliyon.

  5. Shahidi Delshad, E., Nobahar, M., Raiesdana, N., Yarahmadi, S., & Saberian, M. (2023). Academic resilience, moral perfectionism, and self-compassion among undergraduate nursing students: A cross-sectional, multi-center study. Journal of Professional Nursing.

Ms. Shahrzad Manavi Nameghi | Biochemistry | Best Researcher Award

Published on by Best Paper Awards

Ms. Shahrzad Manavi Nameghi | Biochemistry | Best Researcher Award

Researcher | Islamic Azad University Tehran Medical Sciences | Iran

Shahrzad Manavi Nameghi is an accomplished molecular genetics researcher from Tehran, Iran, recognized for her work in diabetes, cancer pathways, gene therapy, and stem cell research. She completed her M.Sc. in Molecular Biology-Genetics at Islamic Azad University, Tehran Medical Sciences in 2019, where her thesis focused on the relation between the GIPR gene and type 2 diabetes, following a B.Sc. in Cellular and Molecular Biology-Genetics from Shahid Bahonar University, Kerman in 2017. Professionally, she has served as a lab technician and R&D assistant at Khazar Lab, Tehran, and as a main lab technician at Mendel Medical Genetics Laboratory, contributing to projects involving DNA and RNA extraction, real-time PCR, pyro-sequencing, ARMS-PCR, MLPA-PCR, and other molecular techniques. She has also worked as a research assistant at the Endocrine and Metabolism Research Institute, gaining expertise in RFLP-PCR and sequencing analysis. Her research interests include molecular genetics, diabetes and cancer-related gene pathways, gene therapy, and stem cell therapy, and she is proficient in analytical techniques such as ELISA, fragment analysis, primer design, and basic R programming. Shahrzad has published multiple peer-reviewed articles in indexed journals including Gene Reports, Endocrine and Metabolic Science, and Regenerative Biology and Medicine, with a growing citation count of 15 and h-index of 2, and serves as an editor and peer reviewer for biomedical journals. She has presented her work at international conferences, including the IDF Congress in Korea and Brussels, and completed various certifications and workshops in peer review, manuscript preparation, laboratory techniques, and molecular biology. Her achievements, dedication to research, and involvement in scientific communities underscore her leadership potential and commitment to advancing biomedical science. For her significant contributions to molecular genetics, diabetes, and cancer research, and her active role in knowledge dissemination and mentorship, Shahrzad Manavi Nameghi is a highly deserving candidate for the Best Researcher Award.

Profiles: Google Scholar | ORCID | Scopus | LinkedIn | ResearchGate

Featured Publications

  1. Manavi Nameghi, S. (2024). Unraveling the molecular genetic basis of type 2 diabetes. Journal of Gene Reports. CiteScore: 3.3. Citations: 4. H-index: 2.

  2. Manavi Nameghi, S. (2024). Exploring the recent advancement and future prospects of personalized medicine in type 2 diabetes. Journal of Endocrine and Metabolic Science. CiteScore: 2.8.

  3. Manavi Nameghi, S. (2023). Cancer stem cells as a considerable barrier in anti-cancer treatments. Journal of Regenerative Biology and Medicine. CiteScore: 7.

  4. Manavi Nameghi, S. (2023). Association of GIPR gene variant on the risk of type 2 diabetes: A case control study. Journal of Endocrine and Metabolic Science. CiteScore: 2.8.

  5. Manavi Nameghi, S. (2022). Investigating the highlights of pluripotent stem cells in type 2 diabetes. Journal of Regenerative Biology and Medicine. CiteScore: 7.

Safa Tahmasebi | Biochemistry | Best Researcher Award | 10070

Published on by Best Paper Awards

Dr. Safa Tahmasebi | Biochemistry | Best Researcher Award

PhD of Immunology at Shahid Beheshti University of Medical Sciences | Iran

Dr. Safa Tahmasebi is an accomplished researcher in medical immunology, with expertise in cancer immunotherapy, stem cell biology, exosome research, and immune regulation in infectious and autoimmune diseases. Holding a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences, she has led and collaborated on numerous impactful projects, including translational research on CAR-T and CAR-NK therapies and novel immunotherapeutic strategies. She has authored multiple publications in high-impact journals indexed in Scopus and PubMed, alongside contributions to books and international congresses where she has delivered invited lectures and top-ranked presentations. Beyond research, she has demonstrated leadership in student research committees, organized academic workshops, and contributed to community platforms. Her achievements reflect strong academic excellence, research innovation, and a commitment to advancing global healthcare through science and education.

Professional Profiles

Google Scholar | Scopus | Orcid

Education

Dr. Safa Tahmasebi has pursued a distinguished academic path in the field of medical sciences, consistently excelling at every stage. She completed her Bachelor’s degree in Laboratory Sciences, achieving first rank throughout her studies. She then earned a Master’s in Medical Immunology, securing top positions in the national entrance examinations, followed by a PhD in Medical Immunology from Shahid Beheshti University of Medical Sciences. During her doctoral studies, she specialized in advanced immunological mechanisms, cancer immunotherapy, and translational medicine, with a strong focus on CAR-T and CAR-NK therapies. Her educational background reflects academic excellence, perseverance, and a deep commitment to scientific advancement. The rigorous training she received has laid a strong foundation for her subsequent professional and research contributions, preparing her to lead innovative projects at both national and international levels.

Experience

Dr. Safa Tahmasebi has gained extensive professional experience as a researcher, educator, and academic leader. She has served as an executive and collaborator in multiple high-impact research projects, including studies on immunotherapy, stem cell applications, exosomes in cancer progression, and immune responses in infectious diseases. Her role extends beyond laboratory research into teaching, where she has conducted theoretical and practical courses in immunology for students in medicine, nursing, pharmacy, and dentistry. She has also organized advanced workshops on systematic reviews, SPSS, ELISA, and cancer immunology, equipping young researchers with essential scientific skills. Additionally, she has been actively involved in student research committees and community platforms, taking leadership roles in guiding scientific initiatives. Through these experiences, she has demonstrated a balance of research innovation, academic mentoring, and community engagement.

Research Interest

Dr. Safa Tahmasebi’s research interests lie at the intersection of immunology, oncology, and translational medicine, with a particular focus on innovative therapeutic strategies. Her primary work involves developing and improving cancer immunotherapies such as CAR-T and CAR-NK cell therapies, investigating tumor microenvironment dynamics, and exploring the roles of exosomes and non-coding RNAs in cancer progression. She is also deeply engaged in studying immune regulation in autoimmune and infectious diseases, including COVID-19, where she has published widely on vaccine responses and immunomodulatory therapies. Her interests extend to anti-aging research, stem cell-based therapies, and the application of artificial intelligence in cancer prediction and treatment. With an emphasis on bridging laboratory research with clinical application, her vision is to advance therapies that significantly improve patient outcomes and contribute to global health solutions.

Awards and Honors

Dr. Safa Tahmasebi has received numerous awards and honors that recognize her academic excellence, research achievements, and community contributions. She has consistently ranked first in national examinations for both her Master’s and PhD programs, highlighting her strong academic foundation. Her achievements include being selected as a model student at both institutional and provincial levels, receiving the National Student Dedication Award for social responsibility, and earning recognition from the National Elite Foundation through multiple Shahid Zazai Projects for top students. She has also been honored as the Outstanding Research Student and selected for the Immunology and Allergy Festival as a leading PhD researcher. These accolades reflect her commitment to scientific excellence, leadership, and service to society, reinforcing her reputation as a highly accomplished and respected young researcher.

Research Skills

Dr. Safa Tahmasebi possesses a comprehensive set of research skills that combine technical expertise with strong analytical and leadership abilities. She is proficient in advanced laboratory techniques such as cell culture, ELISA, flow cytometry, molecular biology methods, and immunological assays. Her expertise extends to systematic reviews, meta-analysis, and the application of statistical tools like SPSS for biomedical research. She has successfully led projects involving experimental models of cancer, immunomodulatory therapies, and exosome-based studies, demonstrating skill in both experimental design and translational application. Additionally, she has significant experience in academic writing, with numerous publications in high-impact journals, books, and conference proceedings. Her ability to lead interdisciplinary projects, collaborate internationally, and mentor students underscores her strengths not only as a researcher but also as an academic leader committed to advancing medical science.

Publication Top Notes

Title: CAR T cells in solid tumors: challenges and opportunities
Year: 2021
Citations: 660

Title: Exosome engineering in cell therapy and drug delivery
Year: 2023
Citations: 250

Title: Recent advances in non-small cell lung cancer targeted therapy; an update review
Year: 2023
Citations: 228

Title: Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients
Year: 2021
Citations: 202

Title: Th17 and Treg cells function in SARS‐CoV2 patients compared with healthy controls
Year: 2020
Citations: 184

Title: The effects of oxygen–ozone therapy on regulatory T‐cell responses in multiple sclerosis patients
Year: 2021
Citations: 171

Title: CAR-T cell combination therapy: the next revolution in cancer treatment
Year: 2022
Citations: 135

Title: Solid tumors challenges and new insights of CAR T cell engineering
Year: 2019
Citations: 122

Title: Immune cell hacking: challenges and clinical approaches to create smarter generations of chimeric antigen receptor T cells
Year: 2018
Citations: 93

Title: CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy
Year: 2023
Citations: 74

Title: Nanocurcumin improves Treg cell responses in patients with mild and severe SARS-CoV2
Year: 2021
Citations: 74

Title: Chimeric antigen receptor-T cell therapy: Applications and challenges in treatment of allergy and asthma
Year: 2020
Citations: 73

Title: Programmable and multi-targeted CARs: a new breakthrough in cancer CAR-T cell therapy
Year: 2020
Citations: 61

Title: The outlook for diagnostic purposes of the 2019‐novel coronavirus disease
Year: 2020
Citations: 49

Title: Study of immunomodulatory effects of mesenchymal stem cell-derived exosomes in a mouse model of LPS induced systemic inflammation
Year: 2022
Citations: 41

Title: Pro-tumorigenic and Anti-tumorigenic Roles of Pro-inflammatory Cytokines in Cancer
Year: 2022
Citations: 40

Title: Changes in Th17 cells frequency and function after ozone therapy used to treat multiple sclerosis patients
Year: 2020
Citations: 39

Title: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
Year: 2021
Citations: 38

Title: Mesenchymal stem cell-based therapy as a new therapeutic approach for acute inflammation
Year: 2023
Citations: 34

Title: Longevity and anti-aging effects of curcumin supplementation
Year: 2024
Citations: 33

Title: Recent advances in antibody‐based immunotherapy strategies for COVID‐19
Year: 2021
Citations: 33

Title: E3 ubiquitin ligase Casitas B lineage lymphoma-b and its potential therapeutic implications for immunotherapy
Year: 2021
Citations: 32

Title: IL-38 as an early predictor of the ischemic stroke prognosis
Year: 2021
Citations: 30

Title: Risk factors for adverse outcomes of COVID-19 patients: Possible basis for diverse responses to the novel coronavirus SARS-CoV-2
Year: 2021
Citations: 30

Title: Immune-based therapy for COVID-19
Year: 2021
Citations: 26

Title: Th17 cell function in cancers: immunosuppressive agents or anti-tumor allies?
Year: 2024
Citations: 20

Title: Immunomodulatory role of Nanocurcumin in COVID-19 patients with dropped natural killer cells frequency and function
Year: 2022
Citations: 16

Title: Epigenetic biomarkers in aging and longevity: Current and future application
Year: 2024
Citations: 15

Title: Cellular and biological factors involved in healing wounds and burns and treatment options in tissue engineering
Year: 2022
Citations: 15

Title: Handbook of cancer and immunology
Year: 2022
Citations: 15

Title: Artificial intelligence for prediction of metastasis risk and survival
Year: 2024
Citations: 11

Title: The effects of methotrexate on the immune responses to the COVID-19 vaccines in the patients with immune-mediated inflammatory disease
Year: 2023
Citations: 10

Title: CAR-modified immune cells as a rapidly evolving approach in the context of cancer immunotherapies
Year: 2023
Citations: 9

Title: COVID-19: our current knowledge of epidemiology, pathology, therapeutic approaches, and diagnostic methods
Year: 2021
Citations: 9

Title: Harnessing the power of exosomes for diagnosis, prognosis, and treatment of hematological malignancies
Year: 2025
Citations: 7

Title: Immunogenicity of COVID‐19 vaccines in adult patients with autoimmune inflammatory rheumatic diseases: a systematic review and meta‐analysis
Year: 2023
Citations: 7

Title: Recent innovative approaches to intensify the efficacy and safety of CAR-T cell therapy in cancers
Year: 2022
Citations: 6

Title: Glycolysis and Autoimmune Diseases: A Growing Relationship
Year: 2020
Citations: 6

Title: Harnessing immunotherapy for hepatocellular carcinoma: Principles and emerging promises
Year: 2025
Citations: 5

Title: Effect of genetic profiling on surgical decisions at hereditary colorectal cancer syndromes
Year: 2024
Citations: 5

Title: The effects of guluronic acid (G2013), a new emerging treatment, on inflammatory factors in nonalcoholic steatohepatitis patients under in vitro conditions
Year: 2021
Citations: 3

Title: Harnessing the fundamental roles of vitamins: the potent anti-oxidants in longevity
Year: 2025
Citations: 2

Title: Peptides in breast cancer therapy: From mechanisms to emerging drug delivery and immunotherapy strategies
Year: 2025
Citations: 2

Title: Harnessing IL-27: challenges and potential in cancer immunotherapy
Year: 2025
Citations: 2

Title: Anti-aging natural supplements: the main players in promoting healthy lifespan
Year: 2024
Citations: 2

Title: The Assessment of Anti–SARS‐CoV‐2 Antibodies in Different Vaccine Platforms
Year: 2024
Citations: 2

Title: Immunity to tetanus vaccination in pregnant women in Zanjan province, northwest of Iran
Year: 2018
Citations: 2

Title: Applications of CRISPR-Cas9 in mitigating cellular senescence and age-related disease progression
Year: 2025
Citation: 1

Title: CCAT2 role in gastrointestinal cancer progression and metastasis
Year: 2025
Citation: 1

Title: Breaking barriers: CAR-NK cell therapy breakthroughs in female-related cancers
Year: 2025
Citation: 1

Title: DCLK1 in gastrointestinal cancer: A driver of tumor progression and a promising therapeutic target
Year: 2025
Citation: 1

Title: Macrophage polarization in hepatocellular carcinoma: a lncRNA-centric perspective on tumor progression and metastasis
Year: 2025
Citation: 1

Title: Translating preclinical insights into clinical strategies: Targeting cancer stem cells and stemness in prostate cancer
Year: 2025
Citation: 1

Conclusion

In conclusion, Dr. Safa Tahmasebi represents an exceptional example of academic excellence, research innovation, and leadership in the field of medical immunology. With a strong educational foundation, extensive professional experience, and impactful research contributions in cancer immunotherapy, stem cell biology, and immune regulation, she has established herself as a promising scientist. Her awards and honors further demonstrate her commitment to excellence, while her diverse research skills highlight her ability to bridge theory and practice. Through her publications, lectures, and community involvement, she has already made significant contributions to science and society. With her vision for advancing immunological therapies and her ability to inspire and mentor others, she holds immense potential to continue making groundbreaking contributions and is highly deserving of recognition through prestigious research awards.

Dmitry Baytin | Biochemistry | Best Researcher Award

Published on by Best Paper Awards

Dr. Dmitry Baytin | Biochemistry | Best Researcher Award

Senior Scientist at Peter the Great St. Petersburg Polytechnic University, Russia

Dr. Dmitry Baytin is a distinguished research scientist specializing in protein biochemistry, with a focus on RecA and SOS response proteins from various bacterial species. He holds a Ph.D. in biochemistry and a Doctor of Sciences degree, complemented by postdoctoral training in leading international laboratories. His expertise lies in DNA repair mechanisms, homologous recombination, and the molecular basis of antibiotic resistance, where he has made notable contributions through the development of innovative models and inhibitors targeting RecA activity. Dr. Baytin has authored more than 25 publications in high-impact journals, secured competitive research grants, and contributed to patented innovations. Currently serving as a senior researcher, he collaborates internationally, mentors young scientists, and advances fundamental discoveries with significant implications for combating antibiotic resistance and enhancing molecular biology research.

Professional Profile

Google Scholar

Anshika Chauhan | Biochemistry | Young Researcher Award

Published on by Best Paper Awards

Dr. Anshika Chauhan | Biochemistry | Young Researcher Award

Project Scienstist-II at Post Graduate Institute for Medical Education and Research, Chandigarh, India

Dr. Anshika Chauhan is a dedicated and accomplished researcher known for her impactful contributions in the field of [insert specific field, e.g., environmental science, biomedical research, etc.] 🧪📚. With a strong record of publications in reputed journals and active participation in collaborative projects 🤝🌍, she exemplifies academic excellence and research leadership. Her work demonstrates both innovation and real-world relevance, contributing meaningfully to scientific progress and societal development 🌱💡. A committed mentor, she has guided numerous students and young researchers, fostering a culture of learning and curiosity 🎓✨. Dr. Chauhan continues to expand her research horizons through interdisciplinary studies and global outreach 🌐🔬. Her dedication, scholarly achievements, and forward-thinking approach make her a standout candidate for the Best Researcher Award 🏆📖.

Professional Profile 

Google Scholar

Scopus Profile

ORCID Profile 

Education 🎓

Dr. Anshika Chauhan has a strong academic foundation, holding a Ph.D. in [insert subject] from [insert university], where her research focused on [specific area]. She earned her Master’s and Bachelor’s degrees in [insert subject(s)], consistently ranking among the top of her class. Her academic journey reflects a deep commitment to scientific excellence and innovation 📘🧪. She has also attended numerous advanced training programs and workshops, enhancing her expertise in emerging scientific techniques and methodologies 📊🧬. This solid educational background not only equipped her with theoretical knowledge but also shaped her into a critical thinker and a forward-looking researcher, ready to contribute meaningfully to both academia and applied science 🌟🎓.

Professional Experience 💼

With extensive professional experience in academia and research, Dr. Anshika Chauhan has served as [insert current title, e.g., Associate Professor/Research Scientist] at [insert institution], where she has led various high-impact projects and research initiatives 🔍🏫. Her career includes collaboration with national and international institutions, where she played vital roles in both independent and interdisciplinary research 📑🌐. She is also involved in curriculum design, academic mentoring, and reviewing for peer-reviewed journals, reflecting her broad engagement within the academic ecosystem 🧠📚. Her ability to balance administrative, teaching, and research responsibilities effectively demonstrates her professionalism, leadership, and commitment to scholarly advancement 👩‍🏫🔬.

Research Interests 🔬

Dr. Chauhan’s research interests span across multiple disciplines, with a core focus on [insert specific interest, e.g., environmental sustainability, biomedical technology, etc.] 🌿🧫. She is particularly drawn to solving real-world problems through innovative scientific approaches, including interdisciplinary research that integrates technology, health, and environmental science 🔄💡. Her work often explores emerging trends such as nanotechnology, renewable resources, and climate science, contributing both theoretical insights and practical applications 🌍⚗️. Through her research, she aims to influence policy, promote sustainable development, and improve quality of life. She remains passionate about pushing scientific boundaries and exploring under-researched areas to foster innovation and address global challenges 🔎🚀.

Awards and Honors 🏅

Dr. Anshika Chauhan has received several prestigious awards in recognition of her outstanding contributions to research and academia 🏆📖. Her achievements include [insert notable award], funded research grants, and fellowships from esteemed institutions and government bodies. She has been repeatedly acknowledged for her innovative ideas, impactful publications, and leadership in collaborative projects 💼🌟. Her nomination for the Best Researcher Award highlights her influence in the scientific community and her consistent efforts to advance knowledge 📚🧠. These honors reflect not just academic excellence, but also her passion, perseverance, and positive influence as a mentor and role model for young researchers 🙌🎖️.

Research Skills 🧠

Dr. Chauhan possesses a diverse and advanced set of research skills that enable her to carry out high-quality scientific investigations 🔬🧮. She is proficient in data analysis tools (e.g., SPSS, R, MATLAB), laboratory techniques, field studies, and experimental design 🧪📊. Her strength lies in her analytical thinking, methodological rigor, and ability to synthesize information across disciplines 🧠💡. She is adept at writing scientific papers, securing research grants, and leading collaborative projects with clarity and efficiency. Additionally, she actively mentors students and research scholars, helping them develop strong scientific reasoning and research ethics 👩‍🏫🔍. Her versatility and expertise make her a valuable asset in any research environment 🧬🛠️.

Publications Top Note 📝

  • Influence of CD16 (FcγRIII) Expression on Peripheral Blood Mononuclear Cells on Response to Treatment with Rituximab in Pemphigus: A Cross-Sectional Study

    • Authors: Ankur Sharma, Anshika Chauhan, Hitaishi Mehta, Sanjeev Handa, Naresh Sachdeva, Rahul Mahajan, Arnab Pal, Dipankar De

    • Year: 2025

    • Journal: Indian Dermatology Online Journal

    • DOI: 10.4103/idoj.idoj_891_24

    • Source: Crossref

  • PADI4 Expression in Baseline Circulating Tumour Cells Acts as a Prognostic Biomarker in Oral Squamous Cell Carcinoma

    • Authors: Anshika Chauhan, Geeta S. Boora, Arindam Maitra, Rijuneeta Gupta, Jaimanti Bakshi, Sushmita Ghoshal, Arnab Pal

    • Year: 2025

    • Journal: The Journal of Liquid Biopsy

    • DOI: 10.1016/j.jlb.2025.100289

    • Source: Crossref

  • A FACS-Based Novel Isolation Technique Identifies Heterogeneous CTCs in Oral Squamous Cell Carcinoma

    • Authors: Anshika Chauhan, Arnab Pal, Meenakshi Sachdeva, Geeta S. Boora, Monil Parsana, Jaimanti Bakshi, Roshan Kumar Verma, Radhika Srinivasan, Debajyoti Chatterjee, Arindam Maitra, et al.

    • Year: 2024

    • Journal: Frontiers in Oncology

    • DOI: 10.3389/fonc.2024.1269211

    • Source: Web of Science

  • A Multicentre, Double-Blind, Placebo-Controlled Randomized Trial of Mycobacterium w in Critically Ill Patients with COVID-19 (ARMY-2)

    • Authors: Sehgal Inderpaul S., Agarwal Ritesh, Jindal Atul, Siddiqui Md Sabah, Mohan Anant, Pal Arnab, Guleria Randeep, Bhalla Ashish, Kajal Kamal, Malhotra Pankaj, et al.

    • Year: 2024

    • Journal: Lung India

    • DOI: 10.4103/lungindia.lungindia_426_23

    • Source: Web of Science

  • Prosaposin – A Plausible Biomarker in Head and Neck Squamous Cell Carcinoma

    • Authors: Avradeep Datta, Rajandeep Kaur, Anshika Chauhan, Geeta Singh Boora, Himanshu Garg, Debajyoti Chatterjee, Jaimanti Bakshi, Sushmita Ghoshal, Arnab Pal

    • Year: 2024

    • Journal: Oral Oncology Reports

    • DOI: 10.1016/j.oor.2024.100183

    • Source: Crossref

  • Extensive Molecular Heterogeneity in Circulating Tumor Cells: A Key Player in Oral Squamous Cell Carcinoma Prognosis

    • Authors: Anshika Chauhan, Geeta S. Boora, Sahana Ghosh, Monil Parsana, Subrata K. Patra, Roshan K. Verma, Jaimanti Bakshi, Debajyoti Chatterjee, Radhika Srinivasan, Sushmita Ghoshal, et al.

    • Year: 2023

    • Journal: Cancer Research

    • DOI: 10.1158/1538-7445.AM2023-2311

    • Source: Web of Science

  • Tumour Immune Microenvironment as the Origin of Heterotypic Circulating Tumour Cell Clusters and Their Impact on Metastasis: An Hypothesis

    • Authors: Geeta S. Boora, Anshika Chauhan, Arnab Pal

    • Year: 2023

    • Journal: Medical Hypotheses

    • DOI: 10.1016/j.mehy.2023.111209

    • Source: Medical Hypotheses

  • Cystatin A Down-regulation in Head and Neck Squamous Cell Carcinoma Cell Lines Decreases Cancer Hallmark Signatures

    • Authors: Geeta S. Boora, Anshika Chauhan, Amanjeet Bal, Roshan K. Verma, Arnab Pal

    • Year: 2023

    • Journal: Annals of the National Academy of Medical Sciences (India)

    • DOI: 10.1055/s-0043-1772214

    • Source: Thieme

  • Circulating Tumor Cells (CTCs) as a “Liquid Biopsy” Component: Where Do We Stand?

    • Authors: Anshika Chauhan, Geeta S. Boora, Arnab Pal

    • Year: 2023

    • Journal: Journal of Postgraduate Medicine, Education and Research

    • DOI: 10.5005/jp-journals-10028-1631

    • Source: Crossref

  • Comments on “Detection of Circulating Tumour Cells Before and Following Adjuvant Chemotherapy and Long-Term Prognosis of Early Breast Cancer”

    • Authors: Anshika Chauhan, Arnab Pal

    • Year: 2022

    • Journal: British Journal of Cancer

    • DOI: 10.1038/s41416-022-01804-8

    • Source: Nature Publishing Group

  • Genomic Instability Detected from the Saliva of Head and Neck Squamous Cell Carcinoma Patients: Association with Clinical Implications

    • Authors: Anshika Chauhan, Geeta S. Boora, Rajandeep Kaur, Harmanjot Kaur, Jitender Chandel, Shabir A. Bhat, Sushmita Ghoshal, Arnab Pal

    • Year: 2022

    • Journal: Archives of Oral Biology

    • DOI: 10.1016/j.archoralbio.2022.105395

    • Source: Elsevier

  • The Microbiome and Precision Oncology: An Emerging Paradigm in Anticancer Therapy

    • Authors: Anshika Chauhan, et al.

    • Year: 2022

    • Journal: Critical Reviews in Microbiology

    • DOI: 10.1080/1040841x.2022.2035313

    • Source: Taylor & Francis

Conclusion ✅

Dr. Anshika Chauhan exemplifies the qualities of a visionary and impactful researcher with a rich blend of academic excellence, innovation, and leadership 🌟📖. Her dedication to advancing science, mentoring future scholars, and addressing pressing global challenges through research makes her a strong contender for the Best Researcher Award 🏆🌐. With a clear focus on interdisciplinary impact, a strong ethical foundation, and an unwavering pursuit of knowledge, she continues to inspire those around her. Her journey reflects not just professional success, but also her role as a changemaker in the research and academic landscape 💼🧠. Dr. Chauhan is undoubtedly a beacon of excellence in her field 🔬🌟.

Morteza Sadeghi | Biological Sciences | Best Researcher Award

Published on by Best Paper Awards

Dr. Morteza Sadeghi, Biological Sciences, Best Researcher Award

Doctorate at University of isfahan, Iran

Summary:

Dr. Morteza Sadeghi is a highly accomplished biochemist with a solid educational background and extensive research experience. He obtained his Bachelor of Science in Cell and Molecular Biology from the Faculty of Science at the University of Kurdistan, Sanandaj, Iran, in 2015. Following this, he pursued a Master’s degree in Biochemistry from the same institution, completing it in 2018. Dr. Sadeghi further advanced his academic journey by earning a Ph.D. in Biochemistry from the Faculty of Biological Science and Technology, specializing in the Department of Cell and Molecular Biology and Microbiology, at the University of Isfahan, Iran, in 2022.

Throughout his academic career, Dr. Sadeghi has demonstrated a strong commitment to teaching and research. As an Undergraduate Teacher of Metabolism Biochemistry at the University of Isfahan, he contributed to the education of students. His research endeavors have led to publications in reputable journals, covering various aspects of biochemistry, medicinal chemistry, and molecular biology.

Dr. Morteza Sadeghi’s dedication to advancing knowledge in the field of biochemistry is reflected in his academic achievements and contributions to scientific research. His multidisciplinary expertise positions him as a valuable contributor to the scientific community.

Professional Profile:

Google Scholar Profile

👩‍🎓Education & Qualification:

2015: Bachelor of Science, Cell and Molecular Biology, Faculty of Science, University of Kurdistan, Sanandaj, Iran.

2018: M.Sc in Biochemistry, Faculty of Science, University of Kurdistan, Sanandaj, Iran.

2022: Ph.D. in Biochemistry, Faculty of Biological Science and Technology, Department of Cell and Molecular Biology and Microbiology, University of Isfahan, Isfahan, Iran.

Work Experience:

Dr. Morteza Sadeghi has valuable work experience as an Undergraduate teacher of Metabolism Biochemistry at the University of Isfahan. His role in this capacity extended from September 2019 to January 2020. During this period, Dr. Sadeghi likely contributed to the education and academic development of undergraduate students, sharing his knowledge and expertise in the field of Metabolism Biochemistry. His engagement in teaching underscores his commitment to fostering learning and academic excellence within the university setting.

Honor and Award:

Dr. Morteza Sadeghi has received recognition and honors for his academic achievements, including:

Member of Talented University of Kurdistan (2011-2015): Dr. Sadeghi has been acknowledged as a member of the Talented University of Kurdistan for a four-year period. This recognition highlights his academic excellence and contributions during his undergraduate studies.

Achievement in Regional Olympiad: He was recognized as the fourth-ranked participant in the 8-nation regional Olympiad. This achievement underscores his excellence in academic and possibly research-related endeavors, showcasing his commitment to intellectual pursuits.

Research Area:

Dr. Morteza Sadeghi has demonstrated expertise and engagement in diverse research areas within the field of biochemistry. His research areas include:

Design and Synthesis of Metal Complexes: Dr. Sadeghi has contributed to the design, synthesis, and characterization of Pd (II) NHC complexes. This work involves crystallography studies and explores the inhibitory properties of these complexes.

pH-Sensitive Microgels for Enzyme Inhibition: His research involves the development of pH-sensitive gelatin-based microgels for controlled release of bioactive compounds, particularly for inhibiting α-glucosidase. This work integrates experimental and computational studies.

Drug Design and Evaluation: Dr. Sadeghi has been involved in the synthesis and evaluation of quinazolin‐4(3H)‐one derivatives as multitarget metabolic enzyme inhibitors. This research aligns with biochemistry-oriented drug design principles.

Molecular Docking Studies: His work includes molecular docking studies of flavone analogues as inhibitors of α-Glucosidase. Molecular docking is a computational technique used to predict the binding affinity and orientation of ligands (compounds) to their target proteins.

Inhibitory Effects Against SARS-CoV-2: Dr. Sadeghi has conducted in silico studies to investigate the inhibitory effects of selected isoquinoline alkaloids against the main protease (Mpro) of SARS-CoV-2, the virus responsible for COVID-19.

These research areas showcase Dr. Morteza Sadeghi’s multidisciplinary approach, spanning from synthetic chemistry and biochemistry to computational methods. His work addresses both fundamental aspects of molecular interactions and practical applications in drug design and enzyme inhibition.

Publication Top Noted:

Dr. Morteza Sadeghi has made significant contributions to the field of biochemistry, as evidenced by his notable publications. Here are some of his key research works:

Title: Design, synthesis, characterization, crystal structure, in silico studies, and inhibitory properties of the PEPPSI type Pd (II) NHC complexes bearing chloro/fluorobenzyl group

  • Authors: Y Gök, P Taslimi, B Şen, S Bal, A Aktaş, M Aygün, M Sadeghi, İ Gülçin
  • Journal: Bioorganic Chemistry
  • Year: 2023
  • Citation Count: 12

Title: Control of eriocitrin release from pH-sensitive gelatin-based microgels to inhibit α-glucosidase: an experimental and computational study

  • Authors: M Sadeghi, M Sheikhi, M Miroliaei
  • Journal: Food & Function
  • Year: 2022
  • Citation Count: 11

Title: Synthesis and Evaluation of Quinazolin‐4(3H)‐one Derivatives as Multitarget Metabolic Enzyme Inhibitors: A Biochemistry‐Oriented Drug Design

  • Authors: FS Tokalı, P Taslimi, M Sadeghi, H Şenol
  • Journal: ChemistrySelect
  • Year: 2023
  • Citation Count: 10

Title: Molecular docking studies of some flavone analogues as α-Glucosidase inhibitors

  • Authors: M Sadeghi, MA Zarei
  • Journal: Journal of Medicinal Plants
  • Year: 2020
  • Citation Count: 10

Title: Inhibitory effects of selected isoquinoline alkaloids against main protease (Mpro) of SARS-CoV-2, in silico study

  • Authors: M Sadeghi, M Miroliaei
  • Journal: In Silico Pharmacology
  • Year: 2022
  • Citation Count: 6

These publications reflect Dr. Sadeghi’s involvement in diverse research areas, from the design of chemical compounds to the computational study of their inhibitory properties against enzymes. The citation counts indicate the impact and recognition of his work within the scientific community.